Target receptor expression dictates the selective intra-tumoral targeting of CD8+ T cells by eciskafusp alfa in matched PBMCs and TILs from CPI-naïve patients - Top-Institutions - MDSpire

Target receptor expression dictates the selective intra-tumoral targeting of CD8+ T cells by eciskafusp alfa in matched PBMCs and TILs from CPI-naïve patients

By
Amrita Manchala
Eleni Maria Varypataki
Jehad Charo
Pablo Umaña
Christian Klein
Laura Codarri Deak
June 1, 2026
0 min

Frontiers In Immunology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

The University of Texas MD Anderson Cancer Center

Houston, Texas
Key Differentiators
- Oncology
- Immunotherapy
#2

Memorial Sloan Kettering Cancer Center

New York, New York
Key Differentiators
- Oncology
- Immunotherapy
#3

Moffitt Cancer Center

Tampa, Florida
Key Differentiators
- Oncology
- Immunotherapy
#4

Dana-Farber Cancer Institute

Boston, Massachusetts
Key Differentiators
- Oncology
- Immunotherapy
#5

Sylvester Comprehensive Cancer Center

Miami, Florida
Key Differentiators
- Oncology
- Immunotherapy

Original Source(s)

Frontiers In Immunology

Target receptor expression dictates the selective intra-tumoral targeting of CD8+ T cells by eciskafusp alfa in matched PBMCs and TILs from CPI-naïve patients

by Amrita Manchala, Eleni Maria Varypataki, Jehad Charo, Pablo Umaña, Christian Klein, Laura Codarri Deak
June 1, 2026

Related Content

Frontiers In Oncology

Management of toxicities from antibody – drug conjugates in breast cancer

by Ajay Gogia
May 29, 2026

Frontiers In Oncology

Treatment of parotid gland oncocytoma: a case report from a radiation oncologist’s perspective

by Kemeng Zhao, Feifei Hu, Yong Rui Bai
June 1, 2026

Frontiers In Medicine

Ultraviolet radiation as a double-edged regulator of melanocyte function in vitiligo therapy and melanoma carcinogenesis